Myosit 750 mg

Myosit 750 mg | INDICATIONS AND USES

Inositol (Myo-inositol) is indicated in adults for the treatment of:

Polycystic ovary syndrome (PCOS)
Anovulation
Menstrual disorders such as amenorrhea
Hyperandrogenism complaints such as hirsutism, alopecia, acanthosis nigricans, acne
Ovarian hyperthecosis
Insulin resistance
Male infertility

Myosit 750 mg | PHARMACOLOGY

Inositols are important molecules in promoting female fertility and in sustaining physiological pregnancy. Myo-inositol, a major form of Inositol, has an established role in human physiology. Myo-inositol represents the most abundant inositol isomer in humans, and it is commonly found in almost every tissue, particularly in brain, blood, fat, kidney, lung, ovaries, and testes, where it participates in several cellular pathways,Inositol (Myo-inositol) as second messenger of gonadotropins and insulin, it guarantees the correct development of oocytes and the progression of embryogenesis. Available evidence demonstrates that the supplementation with Inositol (Myo-inositol) enhances the probability of achieving pregnancy and reduces the onset of adverse maternal effects and neonatal outcomes. Specifically, in the pursuit of pregnancy, Inositol (Myo-inositol) proved to induce ovulation and restore the physiological menstrual cycle in infertile women, particularly in those with Polycystic ovary syndrome (PCOS). Moreover, Inositol (Myo-inositol) supplementation is also useful for women undergoing Assisted reproductive technology (ART), improving oocyte and embryo quality. During pregnancy, Inositol (Myo-inositol) reduces the risk of altered metabolic conditions like Gestational Diabetes Mellitus (GDM), which may lead to miscarriages or stillborn babies. In addition, Inositol (Myo-inositol) seems to reduce the risk of Neural tube defects (NTDs) in folate-resistant women.

Myosit 750 mg | DOSAGE & ADMINISTRATION

Recommended dosage for lipid-lowering and improving conditions related to peripheral vascular insufficiency ranges from 1500 mg to 4000 mg daily, in divided dosages of two to three times daily with or without food for at least 3 months.Use in children and adolescents: There is a lack of long-term safety data to support the safe use of Inositol (Myo-inositol) in children and adolescents.

Myosit 750 mg | DRUG INTERACTIONS

Concomitant use of anti-diabetic drug and Inositol (Myo-inositol) may result in more reduced blood glucose than only anti-diabetic drug therapy

Myosit 750 mg | SIDE EFFECTS

Common: Well tolerated in recommended dose. Only mild gastrointestinal side effects can be shown with higher doses.

Myosit 750 mg | USE DURING PREGNANCY AND LACTATION

Inositol is possibly safe when taken by mouth during pregnancy. There isn't enough reliable information to know if Inositol (Myo-inositol) is safe to use when breast-feeding.

Myosit 750 mg | PRECAUTIONS & WARNINGS

Patient with diabetes should be cautious about use of this medication.

Myosit 750 mg | THERAPEUTIC CLASS

Nicotinic acid group, Oral nutritional preparations

Myosit 750 mg | STORAGE CONDITIONS

Store in a cool and dry place, away from light & moisture. Keep all medicines out of reach of children.